Craig Blinderman named chief of Supportive Care Service at MSK

Vittoria Bocchi, Julia Brunner, Melissa Yao, Tzippora Chwat-Edelstein named 2024 Kravis WiSE fellows

From left to right: Vittoria Bocchi, Melissa Yao, Julia Brunner, Tzippora Chwat-EdelsteinVittoria Bocchi, Julia Brunner, Melissa Yao, and Tzippora Chwat-Edelstein, four Sloan Kettering Institute researchers, were named 2024 Marie-Josée Kravis Women in Science Endeavor, or Kravis WiSE, fellowship grant recipients.

March 08, 2024

Vol.50 No.10

In Brief

MSKCC receives $400M gift from Kenneth Griffin & David Geffen

Memorial Sloan Kettering Cancer Center received a $400 million gift from Kenneth C. Griffin, Citadel founder and CEO, and David Geffen, founder of the David Geffen Foundation.

December 15, 2023

Vol.49 No.46

In Brief

Mark Agnel Frederick Dawson, Cigall Kadoch, Michelle Monje receive MSK’s 2023 Paul Marks Prize

Mark Agnel Frederick DawsonCigall KadochMichelle MonjeMemorial Sloan Kettering Cancer Center has named three innovative investigators as the recipients of this year’s Paul Marks Prize for Cancer Research.

November 17, 2023

Vol.49 No.43

In Brief

Michel Sadelain, Carl June receive 2024 Breakthrough Prize in Life Sciences

Michel SadelainCarl JuneMichel Sadelain, of Memorial Sloan Kettering Cancer Center, and Carl June, of University of Pennsylvania, are two of the recipients of the 2024 Breakthrough Prize in Life Sciences for the development of chimeric antigen receptor T-cell immunotherapy.

September 22, 2023

Vol.49 No.35

Obituary

Pioneering oncologist Irwin H. Krakoff dies at 100

Irwin H. Krakoff, former director of the University of Vermont Cancer Center who has also served in key jobs at Memorial Sloan-Kettering Cancer Center and MD Anderson Cancer Center, died on Aug. 9 in Savannah, GA.

August 11, 2023

Vol.49 No.32

Clinical Roundup

mRNA pancreatic cancer vaccine trial shows promising results in phase I study

Results from a phase I trial at Memorial Sloan Kettering Cancer Center suggest that treatment with mRNA vaccines (autogene cevumeran) cause an effective and lasting immune response in some patients with pancreatic cancer.

May 12, 2023

Vol.49 No.19

Craig Blinderman named chief of Supportive Care Service at MSK

YOU MAY BE INTERESTED IN

Vittoria Bocchi, Julia Brunner, Melissa Yao, Tzippora Chwat-Edelstein named 2024 Kravis WiSE fellows

MSKCC receives $400M gift from Kenneth Griffin & David Geffen

Mark Agnel Frederick Dawson, Cigall Kadoch, Michelle Monje receive MSK’s 2023 Paul Marks Prize

Michel Sadelain, Carl June receive 2024 Breakthrough Prize in Life Sciences

Pioneering oncologist Irwin H. Krakoff dies at 100

mRNA pancreatic cancer vaccine trial shows promising results in phase I study

Renew today!

Subscriber content

Login